Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Occurrence and Outcome of Dual HIV-1 Infection
Molecular Mechanism of Pseudomonas Invasion of Cells
Assessment of the Implementation and Impact of the
Genetic Mechanisms for Creating Diversity in Mouse MHC
Mechanisms of Motility/Chemotaxis in Bacteria
Recently added grants:
Project 1: Molecular Profiling of the Immune Response in Lyme Disease
Core D: Clinical Recruitment
Project 2: Molecular Signatures of West Nile virus susceptibility
Project 3: Effects of Age on Cellular, Transcriptomic and Biochemical Influenza Signatures
Wake Forest Translational Alcohol Research Center (WF-TARC)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35008-12-0-1
Application #
7577651
Study Section
Project Start
2003-02-18
Project End
2008-02-17
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
$57,513
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Stu
Hurwityz, Daniel /
$64,187
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
Comments
Be the first to comment on this grant